CAR-T Cell Immunotherapy for GD2 Positive Glioma Patients

NCT04406610 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Project terminated due to revision of local regulations

Conditions

Glioma of Brain
CAR-T Cell Immunotherapy

Interventions

BIOLOGICAL: GD2 CAR-T immunotherapy

Sponsor

Fuda Cancer Hospital, Guangzhou